William Flanagan

home / authors / william-flanagan

Articles

BPsupp0314_GE_Lifecycle_200.jpg

An Environmental Lifecycle Assessment of Single-Use and Conventional Process Technology: Comprehensive Environmental Impacts

William Flanagan;Andrew Brown;Matthew Pietrzykowski;Vincent Pizzi;Miriam Monge;Andrew Sinclair
March 15th 2014

An environmental study of single-use process technology for biopharmaceutical manufacturing offers a comprehensive examination of environmental impacts across the full process train using lifecycle assessment.

Figure-2-837495-1408526208135.jpg

An Environmental Lifecycle Assessment of Single-Use and Conventional Process Technology: Comprehensive Environmental Impacts

William Flanagan;Andrew Brown;Matthew Pietrzykowski;Vincent Pizzi;Miriam Monge;Andrew Sinclair
March 1st 2014

An environmental study of single-use process technology for biopharmaceutical manufacturing offers a comprehensive examination of environmental impacts across the full process train using lifecycle assessment.

GE-Figure-5-746269-1408610946183.jpg

An Environmental Life Cycle Assessment Comparing Single-Use and Conventional Process Technology

William Flanagan;Andrew Brown;Matthew Pietrzykowski;Vincent Pizzi;Miriam Monge;Andrew Sinclair
November 2nd 2011

The authors compare the environmental impact of monoclonal antibody production using fixed-in-place processing and single-use systems.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: October 28th 2024 | Updated: November 24th 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 15th 2024 | Updated: November 24th 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 24th 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 22nd 2024 | Updated: November 24th 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
© 2024 MJH Life Sciences

All rights reserved.